Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001178913-24-002524
Filing Date
2024-08-09
Accepted
2024-08-09 16:12:22
Documents
5
Effectiveness Date
2024-08-09

Document Format Files

Seq Description Document Type Size
1 S-8 zk2431788.htm S-8 43472
2 EXHIBIT 5.1 exhibit_5-1.htm EX-5.1 10321
3 EXHIBIT 23.1 exhibit_23-1.htm EX-23.1 3090
4 EXHIBIT 107 exhibit_107.htm EX-FILING FEES 35541
5 image0.jpg GRAPHIC 50049
  Complete submission text file 0001178913-24-002524.txt   162564
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-281435 | Film No.: 241192909
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)